Flow cytometry analysis of Glypican-1 expression by T24 and C3 cells 15 In order to demonstrate the ability of upconversion nanoconjugates coupled to MIL-38 antibodies to 16 target Glypican-1 positive urothelial carcinoma, we used Glypican-1 high T24 and Glypican-1 low C3 (control) 17 urothelial carcinoma cell lines kindly provided by Minomic International Ltd. Affinity of the monoclonal 18 antibody MIL-38 towards urothelial carcinoma cells T24 was described previously 167 and was confirmed by the 19 results of the flow cytometry analysis provided by Minomic International Ltd.
28
International Ltd. demonstrated that the majority of T24 cells (Fig. S1 , red histogram) had the stronger 29 fluorescence than that of C3 cells. Minimal binding to C3 cells was also observed (Fig. S1 , blue histogram).
30
Secondary antibody alone was used as the control for this analysis (Fig. S1 , black histogram). Figure S1 . Flow cytometry analysis demonstrated the binding of MIL-38 antibody to T24 cells and 32 minimal binding to C3 cells. Secondary antibody alone was used as a control. See text for details.
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